To describe the incidence and severity of coronavirus disease 2019 (COVID-19) in rheumatic patients treated with targeted synthetic or biological anti-rheumatic drugs (ts/bDMARDs) compared with the general population living in the same Italian region.
Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?
Monti, Sara;Balduzzi, Silvia;Caporali, Roberto;Montecucco, Carlomaurizio
2020-01-01
Abstract
To describe the incidence and severity of coronavirus disease 2019 (COVID-19) in rheumatic patients treated with targeted synthetic or biological anti-rheumatic drugs (ts/bDMARDs) compared with the general population living in the same Italian region.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
incidence.pdf
accesso aperto
Dimensione
286.1 kB
Formato
Adobe PDF
|
286.1 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
